These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 27731638)
1. Derivatives of 3-Amino-2-methylpyridine as BAZ2B Bromodomain Ligands: In Silico Discovery and in Crystallo Validation. Marchand JR; Lolli G; Caflisch A J Med Chem; 2016 Nov; 59(21):9919-9927. PubMed ID: 27731638 [TBL] [Abstract][Full Text] [Related]
2. High-Throughput Fragment Docking into the BAZ2B Bromodomain: Efficient in Silico Screening for X-Ray Crystallography. Lolli G; Caflisch A ACS Chem Biol; 2016 Mar; 11(3):800-7. PubMed ID: 26942307 [TBL] [Abstract][Full Text] [Related]
3. Discovery of BAZ2A bromodomain ligands. Spiliotopoulos D; Wamhoff EC; Lolli G; Rademacher C; Caflisch A Eur J Med Chem; 2017 Oct; 139():564-572. PubMed ID: 28837921 [TBL] [Abstract][Full Text] [Related]
4. Virtual screen to NMR (VS2NMR): Discovery of fragment hits for the CBP bromodomain. Spiliotopoulos D; Zhu J; Wamhoff EC; Deerain N; Marchand JR; Aretz J; Rademacher C; Caflisch A Bioorg Med Chem Lett; 2017 Jun; 27(11):2472-2478. PubMed ID: 28410781 [TBL] [Abstract][Full Text] [Related]
5. Structural Analysis of Small-Molecule Binding to the BAZ2A and BAZ2B Bromodomains. Dalle Vedove A; Spiliotopoulos D; D'Agostino VG; Marchand JR; Unzue A; Nevado C; Lolli G; Caflisch A ChemMedChem; 2018 Jul; 13(14):1479-1487. PubMed ID: 29770599 [TBL] [Abstract][Full Text] [Related]
6. 7TM X-ray structures for class C GPCRs as new drug-discovery tools. 1. mGluR5. Topiol S; Sabio M Bioorg Med Chem Lett; 2016 Jan; 26(2):484-494. PubMed ID: 26706173 [TBL] [Abstract][Full Text] [Related]
7. Exploration of New and Potent Lead Molecules Against CAAX Prenyl Protease I of Leishmania donovani Through Pharmacophore Based Virtual Screening Approach. Prabhu SV; Tiwari K; Suryanarayanan V; Dubey VK; Singh SK Comb Chem High Throughput Screen; 2017; 20(3):255-271. PubMed ID: 28116998 [TBL] [Abstract][Full Text] [Related]
8. Development of selective DprE1 inhibitors: Design, synthesis, crystal structure and antitubercular activity of benzothiazolylpyrimidine-5-carboxamides. Chikhale R; Menghani S; Babu R; Bansode R; Bhargavi G; Karodia N; Rajasekharan MV; Paradkar A; Khedekar P Eur J Med Chem; 2015; 96():30-46. PubMed ID: 25874329 [TBL] [Abstract][Full Text] [Related]
9. Structure-based discovery of selective BRPF1 bromodomain inhibitors. Zhu J; Zhou C; Caflisch A Eur J Med Chem; 2018 Jul; 155():337-352. PubMed ID: 29902720 [TBL] [Abstract][Full Text] [Related]
10. Discovery of CREBBP Bromodomain Inhibitors by High-Throughput Docking and Hit Optimization Guided by Molecular Dynamics. Xu M; Unzue A; Dong J; Spiliotopoulos D; Nevado C; Caflisch A J Med Chem; 2016 Feb; 59(4):1340-9. PubMed ID: 26125948 [TBL] [Abstract][Full Text] [Related]
11. Structure-based design of novel Chk1 inhibitors: insights into hydrogen bonding and protein-ligand affinity. Foloppe N; Fisher LM; Howes R; Kierstan P; Potter A; Robertson AG; Surgenor AE J Med Chem; 2005 Jun; 48(13):4332-45. PubMed ID: 15974586 [TBL] [Abstract][Full Text] [Related]
12. In silico fragment-mapping method: a new tool for fragment-based/structure-based drug discovery. Yamaotsu N; Hirono S J Comput Aided Mol Des; 2018 Nov; 32(11):1229-1245. PubMed ID: 30196523 [TBL] [Abstract][Full Text] [Related]
13. Computational studies of novel carbonyl-containing diazabicyclic ligands interacting with α4β2 nicotinic acetylcholine receptor (nAChR) reveal alternative binding modes. Kombo DC; Mazurov AA; Strachan JP; Bencherif M Bioorg Med Chem Lett; 2013 Sep; 23(18):5105-13. PubMed ID: 23937977 [TBL] [Abstract][Full Text] [Related]
14. Discovery of potent and selective thienopyrimidine inhibitors of Aurora kinases. McClellan WJ; Dai Y; Abad-Zapatero C; Albert DH; Bouska JJ; Glaser KB; Magoc TJ; Marcotte PA; Osterling DJ; Stewart KD; Davidsen SK; Michaelides MR Bioorg Med Chem Lett; 2011 Sep; 21(18):5620-4. PubMed ID: 21778056 [TBL] [Abstract][Full Text] [Related]
15. The polar warhead of a TRIM24 bromodomain inhibitor rearranges a water-mediated interaction network. Liu J; Li F; Bao H; Jiang Y; Zhang S; Ma R; Gao J; Wu J; Ruan K FEBS J; 2017 Apr; 284(7):1082-1095. PubMed ID: 28207202 [TBL] [Abstract][Full Text] [Related]
16. An in silico exploration of the interaction mechanism of pyrazolo[1,5-a]pyrimidine type CDK2 inhibitors. Li Y; Gao W; Li F; Wang J; Zhang J; Yang Y; Zhang S; Yang L Mol Biosyst; 2013 Sep; 9(9):2266-81. PubMed ID: 23864105 [TBL] [Abstract][Full Text] [Related]
17. Pharmacophore modeling, 3D-QSAR, and in silico ADME prediction of N-pyridyl and pyrimidine benzamides as potent antiepileptic agents. Malik R; Mehta P; Srivastava S; Choudhary BS; Sharma M J Recept Signal Transduct Res; 2017 Jun; 37(3):259-266. PubMed ID: 27607834 [TBL] [Abstract][Full Text] [Related]
18. The "Gatekeeper" Residue Influences the Mode of Binding of Acetyl Indoles to Bromodomains. Unzue A; Zhao H; Lolli G; Dong J; Zhu J; Zechner M; Dolbois A; Caflisch A; Nevado C J Med Chem; 2016 Apr; 59(7):3087-97. PubMed ID: 26982797 [TBL] [Abstract][Full Text] [Related]
19. Discovery of novel α7 nicotinic acetylcholine receptor ligands via pharmacophoric and docking studies of benzylidene anabaseine analogs. Kombo DC; Mazurov AA; Chewning J; Hammond PS; Tallapragada K; Hauser TA; Speake J; Yohannes D; Caldwell WS Bioorg Med Chem Lett; 2012 Jan; 22(2):1179-86. PubMed ID: 22177081 [TBL] [Abstract][Full Text] [Related]
20. Structure-based design of PDK1 inhibitors. Poulsen A; Blanchard S; Soh CK; Lee C; Williams M; Wang H; Dymock B Bioorg Med Chem Lett; 2012 Jan; 22(1):305-7. PubMed ID: 22119465 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]